The Ambitious Goal of Validating Prognostic Biomarkers for Systemic Sclerosis-related Interstitial Lung Disease

被引：2

作者：

Bonella, Francesco ^{[1
]}

Caramaschi, Paola ^{[2
]}

机构：

[1] Univ Duisburg Essen, Univ Hosp, Ruhrlandklin, Dept Pneumol Allergy, D-45239 Essen, Germany

[2] Univ Integrata Verona, Azienda Osped, Rheumatol Unit, Verona, Italy

来源：

JOURNAL OF RHEUMATOLOGY | 2013年 / 40卷 / 07期

关键词：

RESOLUTION COMPUTED-TOMOGRAPHY; SURFACTANT PROTEIN D; PULMONARY; SCLERODERMA; DEATH;

D O I：

10.3899/jrheum.130549

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

页码：1034 / 1036

页数：3

共 20 条

[1]

Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort [J].

Assassi, Shervin ;

Sharif, Roozbeh ;

Lasky, Robert E. ;

McNearney, Terry A. ;

Estrada-Y-Martin, Rosa M. ;

Draeger, Hilda ;

Nair, Deepthi K. ;

Fritzler, Marvin J. ;

Reveille, John D. ;

Arnett, Frank C. ;

Mayes, Maureen D. .

ARTHRITIS RESEARCH & THERAPY, 2010, 12 (05)

[2]

Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis [J].

Baraut, Julie ;

Michel, Laurence ;

Verrecchia, Franck ;

Farge, Dominique .

AUTOIMMUNITY REVIEWS, 2010, 10 (02) :65-73

[3]

Bonella P, 2011, SARCOIDOSIS VASC DIF, V28, P27

[4]

Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis [J].

Centola, Michael ;

Cavet, Guy ;

Shen, Yijing ;

Ramanujan, Saroja ;

Knowlton, Nicholas ;

Swan, Kathryn A. ;

Turner, Mary ;

Sutton, Chris ;

Smith, Dustin R. ;

Haney, Douglas J. ;

Chernoff, David ;

Hesterberg, Lyndal K. ;

Carulli, John P. ;

Taylor, Peter C. ;

Shadick, Nancy A. ;

Weinblatt, Michael E. ;

Curtis, Jeffrey R. .

PLOS ONE, 2013, 8 (04)

[5]

Dirven L, 2013, RHEUMATOLOGY

[6]

Idiopathic Pulmonary Fibrosis Lung Function Is a Clinically Meaningful Endpoint for Phase III Trials [J].

du Bois, Roland M. ;

Nathan, Steven D. ;

Richeldi, Luca ;

Schwarz, Marvin I. ;

Nobles, Paul W. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 186 (08) :712-715

[7]

Can Serum Surfactant Protein D or CC-Chemokine Ligand 18 Predict Outcome of Interstitial Lung Disease in Patients with Early Systemic Sclerosis? [J].

Elhaj, Mona ;

Charles, Julio ;

Pedroza, Claudia ;

Liu, Xiaochun ;

Zhou, Xiaodong ;

Estrada-Y-Martin, Rosa M. ;

Gonzalez, Emilio B. ;

Lewis, Dorothy E. ;

Draeger, Hilda T. ;

Kim, Sarah ;

Arnett, Frank C. ;

Mayes, Maureen D. ;

Assassi, Shervin .

JOURNAL OF RHEUMATOLOGY, 2013, 40 (07) :1114-1120

[8]

Clinically significant interstitial lung disease in limited scleroderma - Histopathology, clinical features, and survival [J].

Fischer, Aryeh ;

Swigris, Jeffrey J. ;

Groshong, Steve D. ;

Cool, Carlyne D. ;

Sahin, Hakan ;

Lynch, David A. ;

Curran-Everett, Douglas ;

Gillis, JoAnn Z. ;

Meehan, Richard T. ;

Brown, Kevin K. .

CHEST, 2008, 134 (03) :601-605

[9]

Surfactant Protein D and KL-6 as Serum Biomarkers of Interstitial Lung Disease in Patients with Scleroderma [J].

Hant, Faye N. ;

Ludwicka-Bradley, Anna ;

Wang, He-Jing ;

Li, Ning ;

Elashoff, Robert ;

Tashkin, Donald P. ;

Silver, Richard M. .

JOURNAL OF RHEUMATOLOGY, 2009, 36 (04) :773-780

[10]

Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis [J].

Kodera, M ;

Hasegawa, M ;

Komura, K ;

Yanaba, K ;

Takehara, K ;

Sato, S .

ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :2889-2896

← 1 2 →